SCHEMBL27751973

SCHEMBL27751973

CNC(F)c1ccc(OC)cc1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.45
HTR2A P28223 1/20 0.39
SLC6A4 P31645 1/20 0.39
KCNH2 Q12809 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP1A1 P04798 1/20 0.39
CYP1B1 Q16678 1/20 0.39
CPS1 P31327 2/20 0.37
MTNR1A P48039 2/20 0.36
MTNR1B P49286 2/20 0.36
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA7 P43166 2/20 0.35
CA9 Q16790 2/20 0.35
CA14 Q9ULX7 2/20 0.35
AMY1A P0DUB6 1/20 0.35
CYP2A6 P11509 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL765606 0.82 CYP2D6 (0.62) CYP2D6HTR2ASLC6A4KCNH2CYP1A2
SCHEMBL28745848 0.78 CPS1 (0.42) CYP2D6CYP1A2CYP1A1CYP1B1CPS1
SCHEMBL28769240 0.78 ADRA2A (0.41) CYP2D6HTR2ACYP1A2CYP1A1CYP1B1
SCHEMBL27778333 0.78 CYP1A2 (0.41) CYP2D6HTR2ASLC6A4KCNH2CYP1A2
SCHEMBL27758591 0.78 ALDH1A1 (0.40) CPS1MTNR1AMTNR1B
SCHEMBL31063437 0.77 CA12 (0.45) CYP2D6CYP1A2CYP1A1CYP1B1CPS1
SCHEMBL8241491 0.77 CA12 (0.45) CYP2D6CYP1A2CYP1A1CYP1B1CPS1
Ammonia Solution, Strong SCHEMBL7990378 0.76 CYP1A2 (0.42) CYP2D6CYP1A2CYP1A1CYP1B1CPS1
SCHEMBL28056382 0.76 CYP1A2 (0.42) CYP2D6CYP1A2CYP1A1CYP1B1CPS1
SCHEMBL23123470 0.74 PDE2A (0.53) CYP2D6HTR2ASLC6A4CYP1A2CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101506203-B 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other syndromes NOVARTIS AG 2013-10-16 CN disclosed
CN-101506203-A 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and o NOVARTIS AG (CH) 2009-08-12 CN disclosed